<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Even after radical surgery for stage II and <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e>, metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> is frequently observed </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to identify the risk of metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> with retrospective clinicopathological study </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemistry was performed to evaluate the expression of Osteopontin (OPN), CD-68, and CD105 in 41 cases of stage II and <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e> tissue </plain></SENT>
<SENT sid="3" pm="."><plain>Stage II and <z:e sem="disease" ids="C0677949" disease_type="Neoplastic Process" abbrv="">stage III colorectal cancer</z:e> patients who had undergone R0 resection were classified into two groups: with metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (m-LM; n = 17) and without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (control; n = 24) </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, double-immunofluorescence staining was performed using antibodies to OPN and CD68 </plain></SENT>
<SENT sid="5" pm="."><plain>OPN-positive cells were frequently colocalized with CD68 immunoreactivity </plain></SENT>
<SENT sid="6" pm="."><plain>OPN and microvascular density expression in the central area were significantly higher in the m-LM (OPN; control 4.3 ± 0.56, m-LV 10.8 ± 1.48, P &lt; 0.05; microvascular density control 18.5 ± 2.86, m-LV 31.4 ± 4.39, P &lt; 0.05), while CD68 expression in the invasive margin was significantly higher in the control group (control 98.9 ± 7.31, m-LV 28.2 ± 3.18, P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that the risk of metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> could be well predicted by immunohistochemical staining of OPN in the central areas, and CD68 in the invasive margins of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>